Company Overview

VIVOS THERAPEUTICS, INC.

VVOS
Annual
Revenue vs. Cost of Revenue
Revenue Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses Operating Income
Net Income
Net Income
Revenue
15M
2024 FY
Net Income
-11M
2024 FY
Shares Outstanding
5M
2024 FY
EPS
-2.22USD
2024 FY
Company Information
SIC Code
3841
CIK Code
1716166
Exchange
Nasdaq
Location
US